An uncommon clinical condition: chronic thrombosis of the inferior vena cava. A case report and review of literature

Monaldi Arch Chest Dis. 2010 Mar;74(1):36-9. doi: 10.4081/monaldi.2010.278.

Abstract

The lifetime incidence of deep vein thrombosis (DVT) is approximately 0.1% in general population and even more uncommon in subjects below 40 years of age. Thrombosis of the inferior vena cava (IVC) is an exceptionally rare clinical condition, with etiological factors similar to lower limb DVT. We present a case of post-traumatic chronic obstruction of the IVC in 41 years-old man, caused by a prolonged squatted position, while he was working as a bricklayer. We visited the patient fifteen years after the onset of the first clinical setting showing a severe post thrombotic syndrome, as a consequence of the already diagnosticated thrombosis, involving predominantly the right inferior leg. Thrombophilia screening tests showed patient to be a heterozygous carrier of methylenetetrahydrofolate reductase (MTHFR) gene mutation. Computed tomography (CT) scan confirmed the thrombotic obstruction of the infrahepatic IVC, both common iliac veins, right external and internal iliac veins, with multiple collateral pathways. Because of thrombosis extension, inherited prothrombotic condition and the young age of the patient, we decided to continue life-long oral anticoagulant therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Chronic Disease
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / deficiency
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Occupational Diseases / complications
  • Thrombophilia / complications
  • Thrombophilia / genetics*
  • Thrombophilia / therapy
  • Tomography, X-Ray Computed
  • Vena Cava, Inferior / diagnostic imaging*
  • Venous Thrombosis / diagnostic imaging*
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / genetics*

Substances

  • Anticoagulants
  • Methylenetetrahydrofolate Reductase (NADPH2)